Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm

NCT02327728 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-12-30

No results posted yet for this study

Summary

To evaluate the efficacy of different botulinum toxin A injection patterns in treating benign essential blepharospasm and to compare their influence on condition of eye surface .

Conditions

  • Blepharospasm

Interventions

PROCEDURE

Botulinum toxin A injection (5 sites: 12.5U)

PROCEDURE

Botulinum toxin A injection (4 sites: 10U)

DRUG

Botulinum toxin A 12.5U

DRUG

Botulinum toxin A 10U

Sponsors & Collaborators

  • YangHui

    lead OTHER

Principal Investigators

  • Hui Yang, MD, PhD · Zhongshan Ophthalmic Center, SunYat-senU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02327728 on ClinicalTrials.gov